- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06336252
Technology Assisted Nudging to Increase Physical Activity Among Hospitalised Medical Patients (SENS4ME)
Technology Assisted Nudging to Increase Physical Activity Among Hospitalised Medical Patients in Hospital and 3 Months After Discharge
Primary Objective To investigate if patients hospitalised for older adults with a decreased level of physical function, either related to a chronic condition e.g., COPD, Congestive heart failure, renal failure; infections; frailty and tendency of falling; orthopaedic surgery - after hip fracture will increase their time spent out of bed during hospitalisation and 3 months after discharge through visual feedback and motivational intervention about physical activities from a new mobile technology.
Hypothesis Patients hospitalised for medical disease will increase their physical activity level during hospitalisation and 3 months after discharge through visual feedback and motivational intervention from a new mobile technology.
Study Overview
Status
Intervention / Treatment
Detailed Description
STUDY DESIGN Description of the protocol The study will be conducted as a randomised multicentre trial including 3 hospitals in Europe (Copenhagen, Stavanger, and Genova). Patients admitted to Department of Respiratory Medicine, Department of Cardiology, and Department of Geriatrics, Department of Orthopaedic disease or Department of Neurology will be included, and they will have their physical activity level measured either with or without a monitor providing visual feedback of time spent bedridden, sitting, standing, and walking. After discharge the feedback will include an ergometer bike or sofa bike connected to the feedback mechanism.
Design A randomised multicentre study design is chosen. All participants will have their physical activity measured during hospitalisation and after discharge. Approximately half of the participants will receive visual feedback about the amount of physical activity from a mobile device placed on the bedside table while hospitalized, and after discharge, they will be provided with an ergometer bike or sofa bike connected to the feedback mechanism.
Allocation of participants The allocation of participants will be done 1 to 1, stratified by age group, gender, and level of mobility, to the control group (no feedback) and intervention group (visual feedback group). We schedule, that 162 patients will be possible to include in the analysis set (54 patients are planned to be included in Denmark, Norway, and Italy). A computer-generated randomisation sequence will be used to assign the participants in each site to the intervention and control arms.
Duration of study participation Each participant will be observed from admission of hospitalisation or until he/she is discharged and followed for 3 months.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Christian Have Dall, PhD
- Phone Number: +4528604402
- Email: christian.have.dall@regionh.dk
Study Locations
-
-
-
Copenhagen, Denmark, 2400
- Recruiting
- Christian Dall
-
Contact:
- Christian H Dall, PhD
- Phone Number: 00 45 28604402
- Email: christian.have.dall@regionh.dk
-
Contact:
- Morten T Kristensen, Professor
- Phone Number: 0045 38635000
- Email: morten.tange.kristensen@regionh.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
An individual will be eligible for study participation if he/she meets the following criteria:
Aged ≥60
- Is admitted to one of the participating departments
- Has signed informed consent
- Reads and speaks Danish, Norwegian, Italian, or English
Exclusion Criteria:
An individual will be excluded from the study if he/she meets any of the following criteria:
- Any condition that, in the opinion of the investigator, makes the person unfit for participation, e.g., delirium and/or psychotic symptoms; moderate or severe depression (GDS>8 (short form)); major surgery; moderate/severe dementia (MoCA≤18); chemotherapy or radiation treatment ongoing at enrolment; moderate/severe frailty (CFS≥6)
- Expected hospitalisation less than 24 hours
- Has allergy towards band aid
- Enrolled in any other clinical study within the duration of the current study.
While these criteria represent the criteria for being observed, only patients observed for at least 24 hours are included in the analysis population. For practical reasons it is not possible to predict those patients eligible for the analysis population at inclusion. Hence, we will monitor more patients than we will analyse (see statistical analysis section).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Arm 1 digital nudging
In hospital Participants in the intervention group will receive usual hospital care and be provided with a sensor collecting data on physical activity level during hospitalisation AND a monitor placed at their bedside that displays information about their physical activity level, in terms of time spent bedridden, sitting, standing, and walking. This information will be visible to the health personnel, the patients, and their relatives. This feedback system is developed and provided by SENS Innovation. After discharge The visual feedback system from SENS will be continued after discharge and include an E-sport biking system provided by 4Mvideo. This integrated new system will combine an ergometer bike or sofa bike installed in the patient's own home or nursing home, and data from the sensor that the participants continue to wear after discharge will go into the SENS system, feeding back a visual track of their activities |
In hospital Participants in the intervention group will receive usual hospital care and be provided with a sensor collecting data on physical activity level during hospitalisation AND a monitor placed at their bedside that displays information about their physical activity level, in terms of time spent bedridden, sitting, standing, and walking. This information will be visible to the health personnel, the patients, and their relatives. This feedback system is developed and provided by SENS Innovation. After discharge The visual feedback system from SENS will be continued after discharge and include an E-sport biking system provided by 4Mvideo. This integrated new system will combine an ergometer bike or sofa bike installed in the patient's own home or nursing home, and data from the sensor that the participants continue to wear after discharge will go into the SENS system, feeding back a visual track of their activities |
No Intervention: Arm 2 usual care
The participants in the non-exposed cohort will receive usual hospital care and be provided with a sensor collecting data on activity level during hospitalisation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time spent out of bed measured in minutes related to the total accelerometer wear time (minutes)
Time Frame: 3 month
|
To assess physical activity a small tri-axial accelerometers is used.
The accelerometer measures activity data in minutes per day.
|
3 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Readmission within 90 days
Time Frame: 3 month
|
Number of readmissions 90 days following discharge
|
3 month
|
Length of stay (days)
Time Frame: 3 month assessment
|
Days of hospitalization
|
3 month assessment
|
Time spent lying down, sitting, standing, and walking measured in minutes related to the total accelerometer wear time (minutes)
Time Frame: 3 month
|
Measured by objective accelerometer
|
3 month
|
Time spent out of bed in hospital in minutes related to the total accelerometer wear time (minutes)
Time Frame: 3 month assessment
|
Measured by objective accelerometer
|
3 month assessment
|
Time spent out of bed after discharge in minutes related to the total accelerometer wear time (minutes)
Time Frame: 3 month
|
Measured by objective accelerometer
|
3 month
|
Quality of life (EQ5D-5L)
Time Frame: 3 month
|
PROM quality of life, increase means better quality of life score
|
3 month
|
- In-hospital fall incidents
Time Frame: 3 month assessment
|
Number of falls
|
3 month assessment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Morten T Kristensen, Professor, Bispebjerg Hospital
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- F-23059441
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
US Department of Veterans AffairsCompleted
Clinical Trials on Digital nudging intervention target to change behavior
-
Chulalongkorn UniversityUnknown
-
LirioCone HealthNot yet recruiting
-
Aga Khan UniversityUnknownBehavioral Assessment of Children | Communicable Diseases in ChildrenPakistan
-
Bispebjerg HospitalTrygFonden, Denmark; Hartmann Fonden; Helsefonden, DenmarkCompletedArthroplasty, Replacement, HipDenmark
-
Columbia UniversityDoris Duke Charitable FoundationActive, not recruitingObesity, InfantUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
University of ExeterCompletedRumination | Worry | Repetitive Negative ThinkingUnited Kingdom
-
Seoul National University HospitalCompleted
-
Allurion TechnologiesCompleted